-- Phase 1 Data Highlight RE104 Favorable Safety Profile and Short Duration Psychoactive Experience -- -- Topline Results from RECONNECT…
Toronto, Ontario--(Newsfile Corp. - July 22, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical…
New BSW program aims to help students build foundational skills toward a life-changing career MILWAUKEE, July 21, 2025 /PRNewswire/ -- Herzing…
New BSW program aims to help students build foundational skills toward a life-changing career MILWAUKEE, July 21, 2025 /PRNewswire/ -- Herzing…
Toronto, Ontario--(Newsfile Corp. - July 21, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an…
Newest solution from Sharecare helps life sciences brands uniquely engage, educate, and activate patients, inspired by evidence-based Chronic Disease Self-Management…
Company focused on obtaining approval for outpatient (at-home) use of IGALMI® for the acute treatment of agitation associated with bipolar…
NEW YORK, July 18, 2025 /PRNewswire/ -- In a strategic move underscoring their shared commitment to combating online abuse, PEN…
Any governments across Canada that claim to prioritize the economy while dismantling our public health care have lost their moral…
Vancouver, British Columbia--(Newsfile Corp. - July 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or…